Bigfoot Biomedical

United States
Milpitas, California, United States, 95035

Company profile

Bigfoot Biomedical company profile

Bigfoot Biomedical is a medical device company changing diabetes care for people with insulin-requiring diabetes. The company developing an end-to-end type 1 diabetes management system using a simple design, cloud connectivity, and human-centered automation. It optimizes the dosing and delivery of insulin through an integrated medical device ecosystem powered by machine learning and enhanced by secure, user-friendly consumer technologies, fundamentally changing the paradigm of care. Biofoot Biomedical ’s pioneering smartphone-enabled systems include both automated infusion pump and connected insulin pen options for consumers and will be delivered via a first-of-its-kind monthly subscription service model. By employing data-driven intelligence across an integrated device ecosystem, they are transforming diabetes care with a fully comprehensive digital drug delivery platform experienced as a service.

Business identity

Contact email
[email protected]
Phone number
408-716-5600
Operating status
Active
Company type
For Profit
Employee range
51-100 employees
Revenue range
$0-$1M
Founded
2014-11-18

Headquarters

Postal code
95035
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
8
Total equity funding
$204.6M
Last funding
Convertible Note / 2022-08-15
Last equity funding
Series Unknown / $57M
Investors
16
Lead investors
7
Founders
4
Articles
116
Exited on
2023-09-05

Founders and investors

Founders

Bryan MazlishJeffrey BrewerJon BrilliantLane Desborough

Lead investors

AbbottBryan MazlishJanus Capital GroupJanus Henderson InvestorsJeffrey BrewerMadryn Asset ManagementQuadrant Capital Advisors

Investors

Cormorant Asset ManagementJanus Henderson InvestorsMadryn Asset ManagementTaiwania Capital Management CorporationVisionnaire Ventures